eXoZymes, Inc.
NCM: EXOZLive Quote
About eXoZymes, Inc.
Healthcare
Biotechnology
eXoZymes, Inc. operates as a development stage biotechnology company. The company focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.
📊 Fundamental Analysis
eXoZymes, Inc. demonstrates a profit margin of 0.0%, which is below the sector average, suggesting competitive pressure.
Return on Equity (ROE) is -132.6%, which indicates that capital utilization is currently under pressure.
At a current price of $11.70, EXOZ currently sits at the 41st percentile of its 52-week range (Range: $7.08 - $18.40).
🏥 Financial Health
🔴
Profit Margin
Weak
✅
Debt/Equity
Excellent
🔴
Return on Equity
Weak
Key Financials
Market Cap
$81.99M
Trailing P/E
--
Forward P/E
--
Beta (5Y)
--
52W High
$18.40
52W Low
$7.08
Avg Volume
4K
Day High
Day Low
📡 Subscribe to ZcoreAI updates
Join the list to get access to:
- Z-Score signals at market open
- New app features and updates
- Exclusive promo for ZcoreAI App